Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Expert Review of Anticancer Therapy
|
May 17, 2018
A look at treatment strategies for relapsed multiple myeloma
Giusy Cetani, Mario Boccadoro, Stefania Oliva
Clinical Hematology International
|
October 1, 2021
Moving Toward Continuous Therapy in Multiple Myeloma
Francesca Bonello, Giusy Cetani, Luca Bertamini, et al.
Current Medicinal Chemistry
|
May 15, 2018
Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma
Mattia D'Agostino, Giulia Gazzera, Giusy Cetani, et al.
Cytotherapy
|
March 11, 2024
Epigenetic challenges on the horizon of chimeric antigen receptor-T
Giuditta Benincasa, Maria Grazia Strozziero, Maria Assunta Di Pastena, et al.
Annals of Hematology
|
July 15, 2020
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
Vincenzo Apolito, Luisa Giaccone, Simone Ferrero, et al.
Frontiers in Cardiovascular Medicine
|
May 10, 2021
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients
Giulia Mingrone, Anna Astarita, Lorenzo Airale, et al.
Cancers
|
April 30, 2021
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction
Anna Astarita, Giulia Mingrone, Lorenzo Airale, et al.
Targeted Oncology
|
September 25, 2023
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience
Danilo De Novellis, Raffaele Fontana, Salvatore Palmieri, et al.
Hematological Oncology
|
January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey
Lisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
European Journal of Haematology
|
October 6, 2024
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Danilo De Novellis, Daniele Derudas, Donatella Vincelli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Expert Review of Anticancer Therapy
|
May 17, 2018
A look at treatment strategies for relapsed multiple myeloma
Giusy Cetani, Mario Boccadoro, Stefania Oliva
Clinical Hematology International
|
October 1, 2021
Moving Toward Continuous Therapy in Multiple Myeloma
Francesca Bonello, Giusy Cetani, Luca Bertamini, et al.
Current Medicinal Chemistry
|
May 15, 2018
Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma
Mattia D'Agostino, Giulia Gazzera, Giusy Cetani, et al.
Cytotherapy
|
March 11, 2024
Epigenetic challenges on the horizon of chimeric antigen receptor-T
Giuditta Benincasa, Maria Grazia Strozziero, Maria Assunta Di Pastena, et al.
Annals of Hematology
|
July 15, 2020
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
Vincenzo Apolito, Luisa Giaccone, Simone Ferrero, et al.
Frontiers in Cardiovascular Medicine
|
May 10, 2021
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients
Giulia Mingrone, Anna Astarita, Lorenzo Airale, et al.
Cancers
|
April 30, 2021
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction
Anna Astarita, Giulia Mingrone, Lorenzo Airale, et al.
Targeted Oncology
|
September 25, 2023
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience
Danilo De Novellis, Raffaele Fontana, Salvatore Palmieri, et al.
Hematological Oncology
|
January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey
Lisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
European Journal of Haematology
|
October 6, 2024
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Danilo De Novellis, Daniele Derudas, Donatella Vincelli, et al.
Page
of 1